Arvinas
A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases
3
Funding Rounds
$111.6m
Money raised
Overview
A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases
-
Website:
- Business model: B2C B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Cr*** M. Cr*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** G. Ho | - | - | |
| Ti Sh | - | - | - |
| Li** Ra** | - | - | - |
Funding series
Funding Series Analysis
The company Arvinas has raised a total of $15m in funding over 3 rounds.
Key Insights:
- Arvinas Series A round: $15m
- Arvinas Series B round, October 2015: $41.6m
- Arvinas Therapeutics funding round, April 2018: $55m
Arvinas Series A round
$15m
Arvinas Series B round, October 2015
$41.6m
Arvinas Therapeutics funding round, April 2018
$55m
Industries
Arvinas is active in the following industries: